查找临床试验

已按「特发性肺纤维化」检索,对应国际通用词 idiopathic pulmonary fibrosis

试验不在中国怎么办?

共找到 13 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募II 期中国有中心NCT07447102

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

China

年龄 40 Years – 不限

Dragonboat Biopharmaceutical Company Limited

正在招募早期 I 期中国有中心NCT06267183

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

China

年龄 18 Years – 45 Years

Shanghai Synvida Biotechnology Co.,Ltd.

正在招募III 期中国有中心NCT07464912

A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

China

年龄 40 Years – 80 Years

Beijing Tide Pharmaceutical Co., Ltd

正在招募II 期中国有中心NCT07652658

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

United States、Argentina、Australia、Bulgaria、Canada 等 12 国

年龄 40 Years – 不限

AstraZeneca

正在招募不适用中国有中心NCT07019714

Daoyin Technique for Improving Exercise Endurance in IPF

China

年龄 40 Years – 85 Years

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

正在招募III 期中国有中心NCT07082842

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

China

年龄 40 Years – 80 Years

Sunshine Lake Pharma Co., Ltd.

正在招募II 期NCT07284459

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Argentina、Australia、Canada、Chile、France 等 12 国

年龄 40 Years – 不限

Contineum Therapeutics

正在招募II 期NCT07230288

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

United States、Australia、Bulgaria、Canada、France 等 12 国

年龄 40 Years – 不限

AbbVie

正在招募不适用中国有中心NCT07820254

Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients

China

年龄 18 Years – 80 Years

Shanghai Pulmonary Hospital, Shanghai, China

正在招募II 期中国有中心NCT07121413

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

China

年龄 40 Years – 不限

Shanghai Synvida Biotechnology Co.,Ltd.

正在招募不适用中国有中心NCT06914713

Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF

China

年龄 40 Years – 85 Years

Henan University of Traditional Chinese Medicine

正在招募II 期 / III 期中国有中心NCT06125327

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

China

年龄 40 Years – 80 Years

Guangzhou JOYO Pharma Co., Ltd